IMDX
Insight Molecular Diagnostics Inc.
NASDAQ: IMDX · HEALTHCARE · DIAGNOSTICS & RESEARCH
$3.83
-8.81% today
Updated 2026-04-29
Market cap
$123.53M
P/E ratio
—
P/S ratio
30.46x
EPS (TTM)
$-1.65
Dividend yield
—
52W range
$2 – $9
Volume
0.3M
Insight Molecular Diagnostics Inc. (IMDX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-874.00%
ROE
-23,603.00%
ROA
-62.70%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2013 | — | $-3.50M | — | — | — |
| 2014 | — | $-4.99M | — | — | — |
| 2015 | — | $-8.73M | — | — | — |
| 2016 | — | $-11.17M | — | — | — |
| 2017 | — | $-19.38M | — | — | — |
| 2018 | — | $-15.75M | — | — | — |
| 2019 | — | $-22.33M | — | — | — |
| 2020 | $1.22M | $-29.93M | -52.55% | -2,443.34% | -2,461.51% |
| 2021 | $2.20M | $-64.10M | 64.60% | -2,444.27% | -2,916.15% |
| 2022 | $958000.00 | $-72.90M | -1.88% | -1,878.60% | -7,609.81% |
| 2023 | $1.50M | $-27.78M | 27.48% | -1,672.39% | -1,848.37% |
| 2024 | $1.88M | $-60.66M | 39.34% | -3,245.14% | -3,225.04% |
| 2025 | $4.05M | $-50.22M | 4.69% | -754.08% | -1,238.52% |